33
Participants
Start Date
September 30, 2012
Primary Completion Date
April 30, 2016
Study Completion Date
February 28, 2017
(FDC) ELV/COBI/FTC/TDF
Antiretroviral treatment
UNC at Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
Lead Sponsor
Duke University
OTHER